• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

Proadrenomedullin predicts severe community-acquired pneumonia among children

byBrian DoughertyandAlex Chan
September 2, 2020
in Emergency, Infectious Disease, Pediatrics, Pulmonology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Among children with community-acquired pneumonia, proadrenomedullin more accurately predicted severe disease than established biomarkers such as C-reactive protein and procalcitonin.

Evidence Rating Level: 2 (Good)

Study Rundown: Health care encounters for community-acquired pneumonia (CAP) among children are both frequent and costly. Though clinical biomarkers like white blood cell count (WBC), C-reactive protein (CRP), and procalcitonin (PCT) offer a more objective assessment of disease status than clinical judgment, these markers have not been shown to possess significantly robust discriminatory value with regards to overall severity. Recently, proadrenomedullin (proADM) – a vasodilatory peptide with antimicrobial and anti-inflammatory properties – has shown promise as a clinical predictor of disease severity among adults with sepsis and lower respiratory tract infections. Data among children, however, are lacking. This prospective cohort study utilized data from the Catalyzing Ambulatory Research in Pneumonia Etiology and Diagnostic Innovations in Emergency Medicine (CARPE DIEM) study and sought to evaluate the predictive capacity of proADM across a variety of clinical scenarios. The primary outcome was disease severity after the initial encounter in the emergency department. It was found that proADM concentrations increased with increasing disease severity, and when included in a single adjusted model with CRP and PCT, only proADM was associated with severe disease in children with CAP. These findings were consistent among children with radiographic CAP. A strength of this study is its relatively large sample size. An important limitation, though, was the use of compositive outcomes with regards to disease severity. Individual outcomes may have varied dramatically within the discrete categorizations and, therefore, proADM levels may not be as predictive for some individuals compared with others. Additionally, the lack of availability of proADM level testing at some institutions may limit its applicability. Overall, this study suggested that proADM levels are more predictive of severe CAP compared with CRP and PCT, two established clinical biomarkers. It may play a role, thus, in triage and clinical decision making among children with CAP.

Click here to read the study in Clinical Infectious Diseases

Relevant reading: Biomarkers and Disease Severity in Children With Community-Acquired Pneumonia

In-depth [prospective cohort study]: Of the 1,142 children in the CARPE DIEM study, proADM levels were available for 369 (mean [SD] age = 6.1 [4.7] years, 48% female). Median proAMD concentration was 0.587 nmol/L, and increased with increasing disease severity: 0.53 nmol/L in mild, 0.56 nmol/L in mild-moderate, 0.61 nmol/L in moderate-severe, and 0.70 nmol/L in severe disease (p = 0.002). When examining individual components of the primary outcome, proADM was found to be significantly elevated among children who were hospitalized, required ICU-level care, had a length of stay greater than 24 hours, received IV fluid boluses or continuous IV fluids for more than 12 hours, or required supplemental oxygen. In the model that combined proADM with CRP and PCT, only proADM was associated with severe disease among children with CAP (OR 2.02, 95% CI 1.06 to 4.03), while CRP (OR 0.98, 95% CI 0.74 to 1.31) and PCT (OR 1.05, 95% CI 0.83 to 1.31) were not. Similarly, among children with radiographic CAP, only proADM levels were significant predictors of severe disease (OR 3.88, 95% CI 1.57 to 11.53). ROC curve analysis showed that a proADM threshold of 0.66 nmol/L maximized sensitivity and specificity of testing. At this cutoff, proADM had an area under the ROC curve (AUC) of 0.64 among children with suspected CAP and 0.77 among children with radiographic CAP.

Image: PD

RELATED REPORTS

Expectant management of patent ductus arteriosus noninferior to early ibuprofen use

SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring

Lebrikizumab effective in treating moderate-to-severe atopic dermatitis

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: community acquired pneumoniapediatricspneumonia
Previous Post

#VisualAbstract: For-profit long term care homes associated with increased extent of COVID-19 outbreaks and related mortality

Next Post

Association of recent stressful life events with mental and physical health in the context of genomic and exposomic liability for schizophrenia

RelatedReports

Wide international variation in survival for periviable neonates
Cardiology

Expectant management of patent ductus arteriosus noninferior to early ibuprofen use

March 30, 2023
Paternal factors associated with short interpregnancy interval
Infectious Disease

SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring

March 29, 2023
Pimecrolimus effective first-line treatment for atopic dermatitis
Chronic Disease

Lebrikizumab effective in treating moderate-to-severe atopic dermatitis

March 29, 2023
Nivolumab may be effective in platinum-resistant ovarian cancer
Obstetrics

Immediate postpartum opioid administration not associated with adverse infant outcomes

March 28, 2023
Next Post
Quick Take: Effect of Developmentally Adapted Cognitive Processing Therapy for Youth With Symptoms of Posttraumatic Stress Disorder After Childhood Sexual and Physical Abuse

Association of recent stressful life events with mental and physical health in the context of genomic and exposomic liability for schizophrenia

#VisualAbstract: Better glucose control with closed-loop system in children with type 1 diabetes

#VisualAbstract: Better glucose control with closed-loop system in children with type 1 diabetes

Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial

Incorporating pharmacists into kidney care model may reduce inappropriate prescription rates

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Expectant management of patent ductus arteriosus noninferior to early ibuprofen use
  • Exhaled volatile organic compounds predict bronchopulmonary dysplasia in preterm infants
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options